REVIEW ARTICLE
SARS-CoV-2 and Therapeutic Approaches
Diksha Chugh1, *, Mamta Bishnoi1
Article Information
Identifiers and Pagination:
Year: 2022Volume: 2
E-location ID: e266695872204260
Publisher ID: e266695872204260
DOI: 10.2174/26669587-v2-e2204260
Article History:
Received Date: 22/9/2021Revision Received Date: 16/11/2021
Acceptance Date: 13/12/2021
Electronic publication date: 23/06/2022
Collection year: 2022

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
In 2019, the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) was first reported in Wuhan, China, affecting the population all over the globe. This ongoing pandemic is creating major havoc and has already taken the lives of many people. It has become really difficult to control the spread of the virus because of its high rate of multiplication in the host and transmission. The virus spreads by the means of droplets or direct contact with the infected person, causing pneumonia-like symptoms, such as fever, dry cough, throat pain, and breathlessness. This review presents the indications, mechanism of action, administration, and adverse effects of some antiviral, antibiotic, and immunomodulatory drugs, that are currently employed in the treatment of SARS-CoV-2. It also presents the effects and benefits of drugs on an infected person, when co-administered together.